Medicare Benefits Schedule - Item 16012

Search Results for Item 16012

Category 3 - THERAPEUTIC PROCEDURES

16012

16012 - Additional Information

Item Start Date:
01-Dec-1991
Description Updated:
01-Jul-2023
Schedule Fee Updated:
01-Nov-2023

Group
T3 - Therapeutic Nuclear Medicine

Intravenous administration of a therapeutic dose of Phosphorous 32

Fee: $2,929.70 Benefit: 75% = $2,197.30 85% = $2,831.00


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change